Both Hylenex and Humalog are approved and on the market. Hylenex is not approved to be use with any insulin. HALO is lookiing for that label expansion or indication, primarily for when insulin is used with a pump. The step after that, and further away, will be the trials for a premixed Hylenex/insulin conbination - similar in concept to the premixed HALO/Roche products.
right and HALO has decided to continue to sell Hylenex itself, as it is already doing for Eye Anesthesia with over 60% of the market- #1- they have already begun to hire new sales force leadership t service endocrinologists- They have chosen to attempt to partner the coformulated variety- Lilly would be the logical choice as they partnered with then Dropped Adocia (ADOC) at the time the Yale picked Halo for their artificial pancreas last summer.